Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 2Uterine Anomalies 1Salpingitis 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Leiomyoma 1Infertility, Female 1Infertility 1Endometritis 1Endometriosis 1

Interventions

estradiol, norethindrone drug combination 9asoprisnil 9Uterine Myomectomy 9telapristone acetate 8Uterine Artery Embolization 8ulipristal acetate 7relugolix 7elagolix 7Estradiol 7vilaprisan 5Norethindrone Acetate 5Mifepristone 5ulipristal 4linzagolix 4Leuprolide 4Tranexamic Acid 3Sodium Chloride 3Hysterectomy 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Saline Solution 2Radiofrequency Ablation 2Progestins 2Lidocaine 2Letrozole 2Goserelin 2Endometrial Ablation Techniques 2Anesthesia, General 2pirfenidone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leiomyoma × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × Clear all
NCT04071574 2023-05-09

CS-EOSP-ICSI

Lebanese University

Phase 1/2 Completed
200 enrolled
Gynecologic

Uterine Anomalies, Endometriosis, Endometritis, Infertility, Infertility, Female, Leiomyoma, Polycystic Ovary Syndrome, Pregnancy, Ectopic, Salpingitis, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡